CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Pharmacokinetics-Driven Optimization of 4(3H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 10, 页码: 4979-4990
作者:  Wang, Z (Wang, Zhen)[ 1 ];  Jiang, XR (Jiang, Xiangrui)[ 1 ];  Zhang, XL (Zhang, Xianglei)[ 1,2 ];  Tian, GH (Tian, Guanghui)[ 3 ];  Yang, RL (Yang, Rulei)[ 3 ]
收藏  |  浏览/下载:137/0  |  提交时间:2019/06/28
Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 卷号: 25, 期号: 17, 页码: 4904-4916
作者:  Xiamuxi, H (Xiamuxi, Hainimu);  Wang, Z (Wang, Zhen);  Li, JF (Li, Jianfeng);  Wang, Y (Wang, Yu);  Wu, CH (Wu, Chunhui)
收藏  |  浏览/下载:112/0  |  提交时间:2017/10/31
Exploration of the 5-bromopyrimidin-4(3H)-ones as potent inhibitors of PDE5 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 卷号: 23, 期号: 17, 页码: 4944-4947
作者:  Gong Xudong;  Wang Guan;  Ren Jing;  Liu Zheng;  Wang Zhen
收藏  |  浏览/下载:36/0  |  提交时间:2013/11/07


©版权所有 ©2017 CSpace - Powered by CSpace